申请人:Celtaxsys, Inc.
公开号:US10350197B2
公开(公告)日:2019-07-16
The present invention is directed to methods of inhibiting LTA4-h in a human patient and method of treating a condition ameliorated by the inhibition of leukotriene A4 hydrolase activity in a human patient comprising administering to said human patient the compound, 4-5-[4-(4-Oxazol-2-yl-phenoxy)-benzyl]-2,5-diaza-bicyclo[2.2.1]hept-2-ylmethyl}-benzoic acid.
本发明涉及抑制人类患者体内 LTA4-h 的方法,以及通过抑制人类患者体内白三烯 A4 水解酶活性来改善病情的治疗方法,包括向所述人类患者施用化合物 4-5-[4-(4-噁唑-2-基-苯氧基)-苄基]-2,5-二氮杂双环[2.2.1]庚-2-基甲基}-苯甲酸。